X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4664) 4664
Publication (238) 238
Book Review (100) 100
Book Chapter (56) 56
Conference Proceeding (4) 4
Book / eBook (3) 3
Dissertation (3) 3
Magazine Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
unfractionated heparin (4165) 4165
humans (3369) 3369
molecular-weight heparin (1964) 1964
index medicus (1548) 1548
female (1479) 1479
anticoagulants - therapeutic use (1369) 1369
male (1358) 1358
hematology (1191) 1191
deep-vein thrombosis (1041) 1041
peripheral vascular disease (1002) 1002
middle aged (991) 991
aged (961) 961
heparin (922) 922
cardiac & cardiovascular systems (868) 868
enoxaparin (861) 861
venous thromboembolism (816) 816
anticoagulants (805) 805
heparin, low-molecular-weight - therapeutic use (774) 774
anticoagulants - adverse effects (758) 758
anticoagulants - administration & dosage (692) 692
heparin - therapeutic use (670) 670
treatment outcome (660) 660
thrombosis (634) 634
risk factors (626) 626
prevention (615) 615
adult (599) 599
thromboembolism (594) 594
medicine, general & internal (566) 566
heparin - adverse effects (556) 556
pharmacology & pharmacy (511) 511
pulmonary-embolism (506) 506
fibrinolytic agents - therapeutic use (477) 477
surgery (472) 472
low-molecular-weight heparin (458) 458
anticoagulation (445) 445
venous thrombosis (443) 443
low molecular weight heparin (414) 414
intravenous unfractionated heparin (402) 402
unstable angina (385) 385
heparin - administration & dosage (384) 384
pulmonary embolism (381) 381
hemorrhage - chemically induced (379) 379
therapy (378) 378
aged, 80 and over (370) 370
acute coronary syndromes (362) 362
metaanalysis (353) 353
percutaneous coronary intervention (352) 352
animals (337) 337
drug therapy (335) 335
venous thrombosis - drug therapy (335) 335
acute myocardial-infarction (333) 333
heparin, low-molecular-weight - administration & dosage (324) 324
thrombocytopenia - chemically induced (317) 317
heparin, low-molecular-weight - adverse effects (312) 312
venous thrombosis - prevention & control (307) 307
risk (299) 299
heparin-induced thrombocytopenia (298) 298
management (298) 298
prospective studies (297) 297
enoxaparin - therapeutic use (296) 296
thromboembolism - prevention & control (294) 294
time factors (294) 294
retrospective studies (289) 289
trial (287) 287
randomized-trial (286) 286
anticoagulants - pharmacology (284) 284
prophylaxis (280) 280
randomized controlled trials as topic (272) 272
care and treatment (270) 270
warfarin (270) 270
initial treatment (264) 264
medicine & public health (256) 256
mortality (256) 256
partial thromboplastin time (250) 250
pregnancy (249) 249
induced thrombocytopenia (248) 248
standard heparin (247) 247
dose-response relationship, drug (244) 244
bivalirudin (243) 243
myocardial infarction - drug therapy (242) 242
aspirin (241) 241
abridged index medicus (240) 240
low-molecular-weight (239) 239
risk assessment (238) 238
deep vein thrombosis (237) 237
deep venous thrombosis (236) 236
glycosaminoglycans (234) 234
platelet aggregation inhibitors - therapeutic use (230) 230
acute disease (227) 227
analysis (225) 225
myocardial-infarction (220) 220
cardiology (217) 217
safety (217) 217
thrombosis - prevention & control (217) 217
clinical trials as topic (215) 215
thrombolytic therapy (213) 213
enoxaparin - administration & dosage (211) 211
low-dose heparin (207) 207
health aspects (206) 206
factor xa inhibitors (205) 205
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4308) 4308
German (157) 157
French (113) 113
Spanish (65) 65
Russian (36) 36
Polish (12) 12
Japanese (6) 6
Italian (5) 5
Czech (4) 4
Portuguese (4) 4
Chinese (2) 2
Korean (2) 2
Serbian (2) 2
Dutch (1) 1
Persian (1) 1
Slovak (1) 1
Slovenian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 07/2007, Volume 5, Issue 7, pp. 1373 - 1379
Journal Article
BLOOD, ISSN 0006-4971, 05/2017, Volume 129, Issue 21, pp. 2864 - 2872
Heparin-induced thrombocytopenia (HIT) is an immune complication of heparin therapy caused by antibodies to complexes of platelet factor 4 (PF4) and heparin.... 
FACTOR 4/HEPARIN ANTIBODIES | ORTHOPEDIC-SURGERY | MOLECULAR-WEIGHT HEPARIN | PLATELET-AGGREGATION TEST | FC-GAMMA-RIIA | HEMATOLOGY | CARDIOPULMONARY BYPASS-SURGERY | TISSUE FACTOR EXPRESSION | 4TS SCORING SYSTEM | UNFRACTIONATED HEPARIN | THROMBOEMBOLIC COMPLICATIONS
Journal Article
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 05/2008, Volume 99, Issue 5, pp. 807 - 818
Journal Article
SHOCK, ISSN 1073-2322, 09/2017, Volume 48, Issue 3, pp. 313 - 320
Journal Article
2000, Fundamental and clinical cardiology, ISBN 9780824702717, Volume 39, xix, 400
Book
by Schulman, Sam and Kakkar, Ajay K and Goldhaber, Samuel Z and Schellong, Sebastian and Eriksson, Henry and Mismetti, Patrick and Christiansen, Anita Vedel and Friedman, Jeffrey and Le Maulf, Florence and Peter, Nuala and Kearon, Clive and Schulman, S and Eriksson, H and Goldhaber, S and Kakkar, A and Kearon, C and Mismetti, P and Schellong, S and Bergqvist, D and Tijssen, J and Prins, M. [=Martin H.] and Robben, S and Büller, H and Otten, H. M and Brandjes, D and Peters, R and Mac Gillavry, M. R and Gan, E and Salem, H and Baker, R and Blomberry, P and Curnow, J and Annichino-Bizzacch, J. M and Brandao Panico, M. D and Timi Ribas, J. R and Fernandes Manenti, E. R and Miranda, F and Moraes, J and Raev, D and Mollov, M and Peneva, M and Milanov, S and Anderson, D and Crowther, M and Dolan, S and Eikelboom, J and Game, M and Kahn, S and Kassis, J and Ritchie, B and Solymoss, S and Rodger, M and Yeo, E and Milot, A and Klinke, P and Chen, W and Zhihong, L and Chunxue, B and Jinming, L and Jiwei, Z and Jie, C and Jina, K and Yuqi, W and Zhongqi, Y and Hua, W and Kejing, Y and Bonan, L and Yadong, Y and Changwei, L and Jin, Z and Yongcheng, D and Spinar, J and Maly, R and Cizek, V and Bercikova, J and Cervinka, P and Lang, P and Jirka, V and Oral, I and Reichert, P and Kotik, L and Pojsl, S and Klimovic, T and Husted, S and Nielsen, H and Friis, E and Skødebjerg Kristensen, K and Mottier, D and El Kouri, D and Bleher, Y and Leroux, L and Boda, Z and Sereg, M and Riba, M and Hiremath, J. S and Kareem, S and Banker, D. N and Gadkari, M and Parakh, R and Suresh, K. R and ... and RE-COVER II Trial Investigators
Circulation, ISSN 0009-7322, 2014, Volume 129, Issue 7, pp. 764 - 772
Dabigatran and warfarin have been compared for the treatment of acute venous thromboembolism (VTE) in a previous trial. We undertook this study to extend those... 
Antagonists & inhibitors | Recurrence | Thrombin | Warfarin | Hemorrhage | Venous thromboembolism | CARDIAC & CARDIOVASCULAR SYSTEMS | FONDAPARINUX | THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | RIVAROXABAN | INITIAL TREATMENT | PERIPHERAL VASCULAR DISEASE | ORAL ANTICOAGULANT-THERAPY | APIXABAN | UNFRACTIONATED HEPARIN | Anticoagulants - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Warfarin - adverse effects | Male | Antithrombins - administration & dosage | Dabigatran | Heparin - adverse effects | Warfarin - administration & dosage | Venous Thromboembolism - drug therapy | Young Adult | Benzimidazoles - administration & dosage | Adult | Female | Benzimidazoles - adverse effects | Venous Thromboembolism - epidemiology | beta-Alanine - analogs & derivatives | Acute Disease | beta-Alanine - adverse effects | Double-Blind Method | Hemorrhage - epidemiology | Risk Factors | beta-Alanine - administration & dosage | Anticoagulants - adverse effects | Antithrombins - adverse effects | Adolescent | Aged | Hemorrhage - chemically induced | Heparin, Low-Molecular-Weight - administration & dosage | Usage | Care and treatment | Dabigatran etexilate | Thromboembolism | Anticoagulants | Benzimidazoles | Heparin, Low-Molecular-Weight | Life Sciences | Venous Thromboembolism | Antithrombins | Heparin | beta-Alanine
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 175, pp. 36 - 46
Abstract Background The optimal anti-coagulant for patients with acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI) has not... 
Cardiovascular | PERCUTANEOUS CORONARY INTERVENTION | CARDIAC & CARDIOVASCULAR SYSTEMS | POLYMER-COATED STENT | THROMBUS ASPIRATION | UNSELECTED PATIENTS | ACCESS SITE | SORT | ASSOCIATION TASK-FORCE | SAFE-PCI | SIROLIMUS-ELUTING STENTS | UNFRACTIONATED HEPARIN | Drug-Related Side Effects and Adverse Reactions - prevention & control | Anticoagulants - administration & dosage | Humans | Middle Aged | Heparin - administration & dosage | Male | Recombinant Proteins - adverse effects | Heparin - adverse effects | ST Elevation Myocardial Infarction - diagnosis | Hirudins - administration & dosage | Dose-Response Relationship, Drug | Percutaneous Coronary Intervention - methods | Female | Registries | Electrocardiography - methods | Peptide Fragments - administration & dosage | ST Elevation Myocardial Infarction - drug therapy | Drug-Related Side Effects and Adverse Reactions - etiology | Treatment Outcome | Combined Modality Therapy | Anticoagulants - adverse effects | Recombinant Proteins - administration & dosage | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Administration, Intravenous | Outcome and Process Assessment (Health Care) | Hirudins - adverse effects | Aged | Non-ST Elevated Myocardial Infarction - drug therapy | Peptide Fragments - adverse effects | Non-ST Elevated Myocardial Infarction - diagnosis | Transluminal angioplasty | Medical research | Mortality | Cardiac patients | Clinical trials | Medicine, Experimental | Anticoagulants (Medicine) | Cardiology | Heart attack | Cardiovascular agents | Hypertension | Heart attacks | Ischemia | Electrocardiography | Acute coronary syndromes | Angina pectoris | Thrombosis | Cardiopulmonary resuscitation--CPR | Clinical outcomes | Blood clots | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 12, pp. 1132 - 1142
Journal Article
Journal Article